Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $4000.0.

  • Atara Biotherapeutics' Other Non Operating Income fell 9927.93% to $4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$74000.0, marking a year-over-year decrease of 11223.14%. This contributed to the annual value of $528000.0 for FY2024, which is 31463.41% up from last year.
  • Per Atara Biotherapeutics' latest filing, its Other Non Operating Income stood at $4000.0 for Q3 2025, which was down 9927.93% from $22000.0 recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Other Non Operating Income registered a high of $555000.0 during Q3 2024, and its lowest value of -$309000.0 during Q3 2022.
  • Over the past 4 years, Atara Biotherapeutics' median Other Non Operating Income value was -$12000.0 (recorded in 2023), while the average stood at -$26933.3.
  • Examining YoY changes over the last 5 years, Atara Biotherapeutics' Other Non Operating Income showed a top increase of 215555.56% in 2024 and a maximum decrease of 64166.67% in 2024.
  • Atara Biotherapeutics' Other Non Operating Income (Quarter) stood at -$69000.0 in 2022, then surged by 82.61% to -$12000.0 in 2023, then crashed by 641.67% to -$89000.0 in 2024, then surged by 104.49% to $4000.0 in 2025.
  • Its Other Non Operating Income stands at $4000.0 for Q3 2025, versus $22000.0 for Q2 2025 and -$11000.0 for Q1 2025.